Pharmaniaga Bhd (PHMA)

Currency in MYR
1.190
0.000(0.00%)
Closed·
PHMA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.1801.200
52 wk Range
0.8251.700
Key Statistics
Bid/Ask
1.18 / 1.20
Prev. Close
1.19
Open
1.18
Day's Range
1.18-1.2
52 wk Range
0.825-1.7
Volume
2.07M
Average Volume (3m)
4.14M
1-Year Change
32.2222%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHMA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.530
Upside
+28.57%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.530
(+28.57% Upside)

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
1.04B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.05%
Dividend Yield
1.45%
Industry Median 5.81%
Annualised payout
0.02
Paid unevenly
5-Years Growth
-34.18%
Growth Streak

PHMA Income Statement

Compare PHMA to Peers and Sector

Metrics to compare
PHMA
Peers
Sector
Relationship
P/E Ratio
26.5x28.1x−0.3x
PEG Ratio
−0.29−0.990.00
Price/Book
3.4x1.8x2.6x
Price / LTM Sales
0.4x2.0x3.1x
Upside (Analyst Target)
21.0%25.0%47.6%
Fair Value Upside
Unlock13.3%5.6%Unlock

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and distributes food supplements. In addition, it distributes and trades diagnostic products; and develops OLIN digital platform, an integrated digital platform for ordering, inventory, billing, and sales operations. Further, the company provides logistics services and primary care products for acute diseases and specialty care products for serious and chronic diseases. Pharmaniaga Berhad was founded in 1994 and is based in Shah Alam, Malaysia.

Employees
3502
Market
Malaysia

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
22.95M1.75%27.31M
Other Institutional Investors
856.67M65.32%1.02B
Public Companies & Retail Investors
431.79M32.93%513.83M
Total
1.31B100.00%1.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Boustead Holdings Berhad35.22%461,823,411549,570
Jakel Capital Sdn. Bhd.14.29%187,429,000223,041

People Also Watch

2.270
INAR
+2.25%
0.320
CAPI
-5.88%
4.42
GAMU
0.00%
0.810
AIRG
-8.47%
0.650
ZETR
0.00%

FAQ

What Is the Pharmaniaga Bhd (PHMA) Stock Price Today?

The Pharmaniaga Bhd stock price today is 1.190 MYR.

What Stock Exchange Does Pharmaniaga Bhd Trade On?

Pharmaniaga Bhd is listed and trades on the Kuala Lumpur Stock Exchange.

What Is the Stock Symbol for Pharmaniaga Bhd?

The stock symbol for Pharmaniaga Bhd is "PHMA."

What Is the Pharmaniaga Bhd Market Cap?

As of today, Pharmaniaga Bhd market cap is 1.560B MYR.

What Is Pharmaniaga Bhd's Earnings Per Share (TTM)?

The Pharmaniaga Bhd EPS (TTM) is 0.048.

When Is the Next Pharmaniaga Bhd Earnings Date?

Pharmaniaga Bhd will release its next earnings report on Nov 13, 2026.

From a Technical Analysis Perspective, Is PHMA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Pharmaniaga Bhd Stock Split?

Pharmaniaga Bhd has split 5 times.

How Many Employees Does Pharmaniaga Bhd Have?

Pharmaniaga Bhd has 3502 employees.

What is the current trading status of Pharmaniaga Bhd (PHMA)?

As of Aug 22, 2026, Pharmaniaga Bhd (PHMA) is trading at a price of 1.190 MYR, with a previous close of 1.190 MYR. The stock has fluctuated within a day range of 1.180 MYR to 1.200 MYR, while its 52-week range spans from 0.825 MYR to 1.700 MYR.

What Is Pharmaniaga Bhd (PHMA) Price Target According to Analysts?

The average 12-month price target for Pharmaniaga Bhd is 1.530 MYR, with a high estimate of 2 MYR and a low estimate of 1.15 MYR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +28.57% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.